Professor Mark Morrison
Professor

Mark Morrison

Email: 
Phone: 
+61 7 344 36957

Availability

Professor Mark Morrison is:
Available for supervision

Fields of research

Biomedical and Clinical Sciences Clinical microbiology Clinical sciences Gastroenterology and hepatology Medical biochemistry and metabolomics Medical microbiology

Qualifications

  • Bachelor of Science, University of New South Wales
  • Masters (Research) of Science, James Cook University
  • Doctor of Philosophy, University of Illinois

Search Professor Mark Morrison’s works on UQ eSpace

384 works between 1990 and 2025
All (384) Journal Article (240) Book Chapter (8) Conference Publication (134) Other Outputs (2)

81 - 100 of 384 works

2022

Journal Article

Changes in the skin microbiome associated with squamous cell carcinoma in transplant recipients

Krueger, Annika, Zaugg, Julian, Lachner, Nancy, Bialasiewicz, Seweryn, Lin, Lynlee L., Gabizon, Sharon, Sobarun, Priyamvada, Morrison, Mark, Soyer, H. Peter, Hugenholtz, Philip and Frazer, Ian H. (2022). Changes in the skin microbiome associated with squamous cell carcinoma in transplant recipients. ISME Communications, 2 (1) 13, 13. doi: 10.1038/s43705-022-00095-7

Changes in the skin microbiome associated with squamous cell carcinoma in transplant recipients

2022

Journal Article

Secreted toxins from Staphylococcus aureus strains isolated from keratinocyte skin cancers mediate pro-tumorigenic inflammatory responses in the skin

Krueger, Annika, Zaugg, Julian, Chisholm, Sarah, Linedale, Richard, Lachner, Nancy, Teoh, Siok Min, Tuong, Zewen K., Lukowski, Samuel W., Morrison, Mark, Soyer, H. Peter, Hugenholtz, Philip, Hill, Michelle M. and Frazer, Ian H. (2022). Secreted toxins from Staphylococcus aureus strains isolated from keratinocyte skin cancers mediate pro-tumorigenic inflammatory responses in the skin. Frontiers in Microbiology, 12 789042, 789042. doi: 10.3389/fmicb.2021.789042

Secreted toxins from Staphylococcus aureus strains isolated from keratinocyte skin cancers mediate pro-tumorigenic inflammatory responses in the skin

2022

Journal Article

Successful Manipulation of the Gut Microbiome to Treat Spontaneous and Induced Murine Models of Colitis

Movva, Ramya, Murtaza, Nida, Giri, Rabina, Png, Chin Wen, Davies, Julie, Alabbas, Saleh, Oancea, Iulia, O'Cuiv, Páraic, Morrison, Mark, Begun, Jakob and Florin, Timothy H. (2022). Successful Manipulation of the Gut Microbiome to Treat Spontaneous and Induced Murine Models of Colitis. Gastro Hep Advances, 1 (3), 359-374. doi: 10.1016/j.gastha.2021.12.008

Successful Manipulation of the Gut Microbiome to Treat Spontaneous and Induced Murine Models of Colitis

2021

Journal Article

Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): a feasibility randomized controlled trial

McFarlane, Catherine, Krishnasamy, Rathika, Stanton, Tony, Savill, Emma, Snelson, Matthew, Mihala, Gabor, Kelly, Jaimon T., Morrison, Mark, Johnson, David W. and Campbell, Katrina L. (2021). Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): a feasibility randomized controlled trial. Nutrients, 13 (12) 4481, 4481. doi: 10.3390/nu13124481

Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): a feasibility randomized controlled trial

2021

Journal Article

Diet quality and protein-bound uraemic toxins: investigation of novel risk factors and the role of microbiome in chronic kidney disease

McFarlane, Catherine, Krishnasamy, Rathika, Stanton, Tony, Savill, Emma, Snelson, Matthew, Mihala, Gabor, Morrison, Mark, Johnson, David W. and Campbell, Katrina L. (2021). Diet quality and protein-bound uraemic toxins: investigation of novel risk factors and the role of microbiome in chronic kidney disease. Journal of Renal Nutrition, 32 (5), 542-551. doi: 10.1053/j.jrn.2021.10.003

Diet quality and protein-bound uraemic toxins: investigation of novel risk factors and the role of microbiome in chronic kidney disease

2021

Journal Article

Draft genome sequence of streptococcus salivarius AGIRA0003, isolated from functional gastrointestinal disorder duodenal tissue

Hoedt, Emily C., Shanahan, Erin R., Keely, Simon, Shah, Ayesha, Burns, Grace L., Holtmann, Gerald J., Talley, Nicholas J. and Morrison, Mark (2021). Draft genome sequence of streptococcus salivarius AGIRA0003, isolated from functional gastrointestinal disorder duodenal tissue. Microbiology Resource Announcements, 10 (39) e00758, e0075821. doi: 10.1128/MRA.00758-21

Draft genome sequence of streptococcus salivarius AGIRA0003, isolated from functional gastrointestinal disorder duodenal tissue

2021

Conference Publication

Differentiation and capture of the human duodenal mucosa-associated microbiota by a novel ex vivo combination of microbe culture and metagenomic sequencing

Schooth, L., Kang, S., Lim, Y., Shah, A., Fairlie, T., Jimenez-Loayza, J., Teh, J.-J., Holtmann, G. and Morrison, M. (2021). Differentiation and capture of the human duodenal mucosa-associated microbiota by a novel ex vivo combination of microbe culture and metagenomic sequencing. GESA AGW 2021, Online, 4-12 September 2021. Richmond, VIC Australia: Wiley-Blackwell.

Differentiation and capture of the human duodenal mucosa-associated microbiota by a novel ex vivo combination of microbe culture and metagenomic sequencing

2021

Journal Article

Concomitant irritable bowel syndrome does not influence the response to antimicrobial therapy in patients with functional dyspepsia

Shah, Ayesha, Gurusamy, Saravana Ruban, Hansen, Teressa, Callaghan, Gavin, Talley, Nicholas J., Koloski, Natasha, Walker, Marjorie M., Jones, Michael P., Morrison, Mark and Holtmann, Gerald J. (2021). Concomitant irritable bowel syndrome does not influence the response to antimicrobial therapy in patients with functional dyspepsia. Digestive Diseases and Sciences, 67 (6), 2299-2309. doi: 10.1007/s10620-021-07149-1

Concomitant irritable bowel syndrome does not influence the response to antimicrobial therapy in patients with functional dyspepsia

2021

Journal Article

Investigation of spaceflight induced changes to astronaut microbiomes

Morrison, Michael D., Thissen, James B., Karouia, Fathi, Mehta, Satish, Urbaniak, Camilla, Venkateswaran, Kasthuri, Smith, David J. and Jaing, Crystal (2021). Investigation of spaceflight induced changes to astronaut microbiomes. Frontiers in Microbiology, 12 659179, 1-15. doi: 10.3389/fmicb.2021.659179

Investigation of spaceflight induced changes to astronaut microbiomes

2021

Journal Article

Novel strain-level resolution of Crohn’s disease mucosa-associated microbiota via an ex vivo combination of microbe culture and metagenomic sequencing

Teh, J. J., Berendsen, E. M., Hoedt, E. C., Kang, S., Zhang, J., Zhang, F., Liu, Q., Hamilton, A. L., Wilson-O’Brien, A., Ching, J., Sung, J. J. Y., Yu, J., Ng, S. C., Kamm, M. A. and Morrison, M. (2021). Novel strain-level resolution of Crohn’s disease mucosa-associated microbiota via an ex vivo combination of microbe culture and metagenomic sequencing. The ISME Journal, 15 (11), 3326-3338. doi: 10.1038/s41396-021-00991-1

Novel strain-level resolution of Crohn’s disease mucosa-associated microbiota via an ex vivo combination of microbe culture and metagenomic sequencing

2021

Journal Article

Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and meta-analysis

Gurusamy, Saravana Ruban, Shah, Ayesha, Talley, Nicholas J., Koloski, Natasha, Jones, Michael P., Walker, Marjorie M., Morrison, Mark and Holtmann, Gerald (2021). Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and meta-analysis. The American Journal of Gastroenterology, 116 (5), 935-942. doi: 10.14309/ajg.0000000000001197

Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and meta-analysis

2021

Conference Publication

Health interventions in chronic kidney disease: Acceptability and feasibility of of synbiotic supplementation

McFarlane, Catherine, Krishnasamy, Rathika, Stanton, Tony, Savill, Emma, Kelly, Jaimon T., Snelson, Matthew, Mihala, Gabor, Morrison, Mark, Johnson, David W. and Campbell, Katrina L. (2021). Health interventions in chronic kidney disease: Acceptability and feasibility of of synbiotic supplementation. 58th ERA-EDTA Congress, Berlin, Germany, 5–8 June 2021. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfab089.003

Health interventions in chronic kidney disease: Acceptability and feasibility of of synbiotic supplementation

2021

Conference Publication

Food additives enhance pro-inflammatory bacterial growth in Crohn's disease mucosa-associated microbiota. The Enigma Study

Kang, Seungha, de Klerk, Ashley, Noon, Ebony, Teh, Jing Jie, Zhang, Jingwan, Zhang, Fen, Liu, Qin, Hamilton, Amy L., Wilson-O'Brien, Amy, Trakman, Gina L., Lin, Winnie Y., Ching, Jessica Y., Sung, Joseph J., Yu, Jun, Ng, Siew C., Kamm, Michael A. and Morrison, Mark (2021). Food additives enhance pro-inflammatory bacterial growth in Crohn's disease mucosa-associated microbiota. The Enigma Study. DDW 2021, Online, 21-23 May 2021. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(21)01036-2

Food additives enhance pro-inflammatory bacterial growth in Crohn's disease mucosa-associated microbiota. The Enigma Study

2021

Conference Publication

Diet quality, protein-bound uraemic toxins and gastrointestinal microbiome in chronic kidney disease

McFarlane, Catherine, Krishnasamy, Rathika, Stanton, Tony, Savill, Emma, Snelson, Matthew, Mihala, Gabor, Morrison, Mark, Johnson, David W. and Campbell, Katrina L. (2021). Diet quality, protein-bound uraemic toxins and gastrointestinal microbiome in chronic kidney disease. 58th ERA-EDTA Congress, Berlin, Germany, 5–8 June 2021. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfab139.002

Diet quality, protein-bound uraemic toxins and gastrointestinal microbiome in chronic kidney disease

2021

Journal Article

Chemoradiation therapy changes oral microbiome and metabolomic profiles in patients with oral cavity cancer and oropharyngeal cancer

Lim, Yenkai, Tang, Kai Dun, Karpe, Avinash V., Beale, David J., Totsika, Makrina, Kenny, Liz, Morrison, Mark and Punyadeera, Chamindie (2021). Chemoradiation therapy changes oral microbiome and metabolomic profiles in patients with oral cavity cancer and oropharyngeal cancer. Head and Neck, 43 (5), 1521-1534. doi: 10.1002/hed.26619

Chemoradiation therapy changes oral microbiome and metabolomic profiles in patients with oral cavity cancer and oropharyngeal cancer

2021

Conference Publication

Gut health interventions in chronic kidney disease: acceptability and feasibility of synbiotic supplementation

McFarlane, Catherine, Krishnasamy, Rathika, Stanton, Tony, Savill, Emma, Kelly, Jaimon T., Snelson, Matthew, Mihala, Gabor, Morrison, Mark, Johnson, David W. and Campbell, Katrina L. (2021). Gut health interventions in chronic kidney disease: acceptability and feasibility of synbiotic supplementation. 58th ERA-EDTA Congress, Virtual, 5–8 June 2021. Oxford, United Kingdom: Oxford University Press.

Gut health interventions in chronic kidney disease: acceptability and feasibility of synbiotic supplementation

2021

Conference Publication

Diet quality, protein-bound uraemic toxins and gastrointestinal microbiome in chronic kidney disease

McFarlane, Catherine, Krishnasamy, Rathika, Stanton, Tony, Savill, Emma, Snelson, Matthew, Mihala, Gabor, Morrison, Mark, Johnson, David W. and Campbell, Katrina L. (2021). Diet quality, protein-bound uraemic toxins and gastrointestinal microbiome in chronic kidney disease. 58th Congress of the European Renal Association (ERA) European Dialysis and Transplant Association (EDTA), Online, 5-8 June 2021. Oxford, United Kingdom: Oxford University Press.

Diet quality, protein-bound uraemic toxins and gastrointestinal microbiome in chronic kidney disease

2021

Journal Article

Characteristics of the gastrointestinal microbiota in paired live kidney donors and recipients

Chan, Samuel, Morrison, Mark, Hawley, Carmel M., Campbell, Scott B., Francis, Ross S., Isbel, Nicole M., Pascoe, Elaine M. and Johnson, David W. (2021). Characteristics of the gastrointestinal microbiota in paired live kidney donors and recipients. Nephrology, 26 (5), 471-478. doi: 10.1111/nep.13853

Characteristics of the gastrointestinal microbiota in paired live kidney donors and recipients

2021

Conference Publication

Sa533 Novel characterization of the secretomes of crohn's disease mucosa-associated microbiota, and their modulation of inflammation through nf-κb signalling. The Enigma Study

Teh, Jing Jie, Kang, Seungha, Schooth, Lauren F., Loayza, Jeimy Johana Jimenez, Zhang, Jingwan, Zhang, Fen, Liu, Qin, Hamilton, Amy L., Wilson-O'Brien, Amy, Ching, Jessica Y., Sung, Joseph J., Yu, Jun, Ng, Siew C., Kamm, Michael A. and Morrison, Mark (2021). Sa533 Novel characterization of the secretomes of crohn's disease mucosa-associated microbiota, and their modulation of inflammation through nf-κb signalling. The Enigma Study. DDW 2021, Virtual, 21-23 May 2021. Philadelphia, PA USA: Elsevier. doi: 10.1016/s0016-5085(21)01989-2

Sa533 Novel characterization of the secretomes of crohn's disease mucosa-associated microbiota, and their modulation of inflammation through nf-κb signalling. The Enigma Study

2021

Journal Article

Microbiome-immune interactions in tuberculosis

Mori, Giorgia, Morrison, Mark and Blumenthal, Antje (2021). Microbiome-immune interactions in tuberculosis. PLoS Pathogens, 17 (4) e1009377, e1009377. doi: 10.1371/journal.ppat.1009377

Microbiome-immune interactions in tuberculosis

Current funding

  • 2024 - 2029
    Centre of Research Excellence in Transforming Gut Health (a 2024 NHMRC Centres of Research Excellence grant led by The University of Newcastle)
    University of Newcastle
    Open grant
  • 2024 - 2027
    Harnessing microbial immunomodulatory function to improve treatment of inflammatory bowel diseases
    NHMRC IDEAS Grants
    Open grant
  • 2023 - 2025
    Investigating gastrointestinal biofilms regarding biochemistry and links with clinical manifestations (2023 MSHRSS Co-funded Collaboration Grant led by MSH)
    Metro South Research Support Scheme Co-funded Collaboration Grant
    Open grant
  • 2022 - 2025
    Defining host immune and microbial determinants of disease trajectory in mycobacterial infection
    Metro South Hospital and Health Service
    Open grant
  • 2022 - 2026
    Microbiome Manipulation to Treat and Cure Inflammatory Bowel Disease (NHMRC Investigator Grant led by CI Kamm University of Melbourne)
    University of Melbourne
    Open grant
  • 2021 - 2025
    Drugs from Bugs: Developing New Inflammatory Bowel Disease Drugs from Gut Bacteria-Derived Bioactives
    United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
    Open grant
  • 2020 - 2025
    Creating an evidence base for clinical care: A randomized controlled study examining the efficacy of the low FODMAP diet for... (MRFF EPCDR Endometriosis Grant led by Monash)
    Monash University
    Open grant
  • 2020 - 2025
    Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Past funding

  • 2024 - 2025
    Onco-Derm: a single site prospective analysis of skin microbiome as a predictor of toxicity in patients receiving immune checkpoint inhibitor therapy
    Microba Pty Ltd
    Open grant
  • 2023 - 2024
    Responses of duodenal spheroid cultures to the secretomes of duodenal microbiota from patients with and without disorders of gut brain interactions (NHMRC CRE led by University of Newcastle)
    University of Newcastle
    Open grant
  • 2022 - 2023
    The effects of variable doses of STW 5 and STW 5-II on bacterial isolates from the duodenum and the duodenal mucosa-associated microbiomes from subjects with and without functional GI symptoms
    Bayer - Steigerwald Arzneimittelwerk GmbH
    Open grant
  • 2022
    Linking the presence of live Ileal-derived bacteria in the joint as a triggering factor for the development of Spondyloarthropathy.
    Arthritis Foundation of Australia
    Open grant
  • 2021 - 2022
    Impacts of food additives on the duodenal mucosa-associated microbiota
    University of Newcastle
    Open grant
  • 2021 - 2024
    Bringing Archaeal biodiversity to life from native Australian herbivores
    ARC Discovery Projects
    Open grant
  • 2020 - 2024
    Modulation of the Gastrointestinal Microbiome with probiotics and subsequent Methane production as a novel approach to treat constipation: A Proof of Principle Study (TRI Sport Grant led by PAH)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2021
    Comparative Genomic Sequencing of selected strains of probiotic bacteria - Phase II
    Innovation Connections
    Open grant
  • 2020 - 2021
    Functionally characterizing IBD dysbiosis and harnessing gut bioactives to suppress IL-23 driven inflammation
    The Global Grants for Gut Health
    Open grant
  • 2019 - 2024
    Centre for Research Excellence in Digestive Health (NHMRC CRE administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2019 - 2020
    Comparative Genomic Sequencing of selected strains of probiotic bacteria
    Innovation Connections
    Open grant
  • 2017 - 2020
    Invention of a Genetic Toolkit for Immunomodulatory Gut Bacteria to Expedite the Development of New Crohn's Disease Therapeutics
    United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
    Open grant
  • 2017 - 2018
    Prebiotic Study of Faecal Samples - Using Diets Rich in Dietary Fibre to Improve Bowel Habit and Sense of Wellbeing
    Monash University
    Open grant
  • 2017 - 2022
    The ENIGMA project: Eastern Inflammatory Bowel Disease Gut Microbiota
    Australasian Gastro Intestinal Research Foundation
    Open grant
  • 2017 - 2020
    Epithelial metabolism as a mediator of host-microbiome interactions in inflammatory bowel disease (NHMRC Project Grant administered by The University of Newcastle)
    University of Newcastle
    Open grant
  • 2017 - 2018
    Linking maternal and infant microbiome: effects of GDM or effects of probiotics?
    Diabetes Australia Research Program
    Open grant
  • 2016 - 2019
    Rapid functional and taxonomic skin microbe characterisation
    ARC Linkage Projects
    Open grant
  • 2016 - 2020
    Design rules for nutritionally-functional grains
    ARC Linkage Projects
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Instrumentation for the analysis of cellular and metabolic phenotypes
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Modification of the microbiome to protect against spondyloarthropathy in SKG mice
    Arthritis Foundation of Australia
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2017
    Microbiome in highly trained athletes and response to dietary change
    Australian Institute Sport
    Open grant
  • 2015
    Design rules for nutritionally-functional starches
    UQ Collaboration and Industry Engagement Fund - Seed Research Grant
    Open grant
  • 2015 - 2017
    Evolution of the marsupial gut microbiome and adaptation to eucalypt toxins
    ARC Discovery Projects
    Open grant
  • 2015 - 2018
    Pathophysiology of functional dyspepsia: Integration of upper gut function, inflammation and a systems biology approach.
    NHMRC Project Grant
    Open grant
  • 2015 - 2016
    Your microbiome or your mother's? The relationship between the microbiomes of mothers and babies
    Royal Brisbane and Women's Hospital
    Open grant
  • 2014 - 2017
    Interactions between host and the gut microbiome in the pathogenesis of ankylosing spondylitis and Crohn's disease
    NHMRC Project Grant
    Open grant
  • 2014 - 2015
    Bringing genomes to life: isolation of genetically tractable, not-yet-cultured members of the human microbiota using metaparental mating methods
    PA Research Foundation
    Open grant
  • 2014 - 2018
    Determinants of progression of actinic keratoses to squamous cancer
    NHMRC Project Grant
    Open grant

Availability

Professor Mark Morrison is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

For media enquiries about Professor Mark Morrison's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au